nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP2C8—Tamoxifen—pancreatic cancer	0.0885	0.13	CbGbCtD
Sitagliptin—CYP2C8—Erlotinib—pancreatic cancer	0.0753	0.111	CbGbCtD
Sitagliptin—CYP2C8—Fluorouracil—pancreatic cancer	0.0652	0.096	CbGbCtD
Sitagliptin—ABCB1—Tamoxifen—pancreatic cancer	0.0599	0.0882	CbGbCtD
Sitagliptin—ABCB1—Gemcitabine—pancreatic cancer	0.0516	0.076	CbGbCtD
Sitagliptin—ABCB1—Erlotinib—pancreatic cancer	0.051	0.075	CbGbCtD
Sitagliptin—ABCB1—Irinotecan—pancreatic cancer	0.046	0.0677	CbGbCtD
Sitagliptin—CYP3A4—Tamoxifen—pancreatic cancer	0.0359	0.0529	CbGbCtD
Sitagliptin—ABCB1—Docetaxel—pancreatic cancer	0.0337	0.0496	CbGbCtD
Sitagliptin—ABCB1—Sunitinib—pancreatic cancer	0.0336	0.0494	CbGbCtD
Sitagliptin—CYP3A4—Erlotinib—pancreatic cancer	0.0305	0.0449	CbGbCtD
Sitagliptin—CYP3A4—Irinotecan—pancreatic cancer	0.0276	0.0406	CbGbCtD
Sitagliptin—ABCB1—Doxorubicin—pancreatic cancer	0.0251	0.037	CbGbCtD
Sitagliptin—CYP3A4—Docetaxel—pancreatic cancer	0.0202	0.0297	CbGbCtD
Sitagliptin—CYP3A4—Sunitinib—pancreatic cancer	0.0201	0.0296	CbGbCtD
Sitagliptin—CYP3A4—Doxorubicin—pancreatic cancer	0.0151	0.0222	CbGbCtD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)—PCSK1—pancreatic cancer	0.00632	0.215	CbGpPWpGaD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—PCSK1—pancreatic cancer	0.00466	0.159	CbGpPWpGaD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—PCSK1—pancreatic cancer	0.00415	0.141	CbGpPWpGaD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—GCG—pancreatic cancer	0.00245	0.0835	CbGpPWpGaD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—GCG—pancreatic cancer	0.00218	0.0743	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—PCSK1—pancreatic cancer	0.00141	0.048	CbGpPWpGaD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—pancreatic cancer	0.000988	0.0337	CbGpPWpGaD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—CTNNB1—pancreatic cancer	0.000878	0.03	CbGpPWpGaD
Sitagliptin—DPP4—Peptide hormone metabolism—GCG—pancreatic cancer	0.000739	0.0252	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—FUT8—pancreatic cancer	0.000435	0.0148	CbGpPWpGaD
Sitagliptin—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000351	0.0012	CcSEcCtD
Sitagliptin—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00035	0.0012	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000348	0.0012	CcSEcCtD
Sitagliptin—Asthenia—Sunitinib—pancreatic cancer	0.000348	0.00119	CcSEcCtD
Sitagliptin—Decreased appetite—Irinotecan—pancreatic cancer	0.000347	0.00119	CcSEcCtD
Sitagliptin—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000346	0.00119	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000346	0.00119	CcSEcCtD
Sitagliptin—Insomnia—Fluorouracil—pancreatic cancer	0.000346	0.00119	CcSEcCtD
Sitagliptin—Somnolence—Gemcitabine—pancreatic cancer	0.000346	0.00119	CcSEcCtD
Sitagliptin—Migraine—Doxorubicin—pancreatic cancer	0.000345	0.00118	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000345	0.00118	CcSEcCtD
Sitagliptin—Fatigue—Irinotecan—pancreatic cancer	0.000344	0.00118	CcSEcCtD
Sitagliptin—Breast disorder—Epirubicin—pancreatic cancer	0.000342	0.00118	CcSEcCtD
Sitagliptin—Constipation—Irinotecan—pancreatic cancer	0.000341	0.00117	CcSEcCtD
Sitagliptin—Pain—Irinotecan—pancreatic cancer	0.000341	0.00117	CcSEcCtD
Sitagliptin—Mental disorder—Docetaxel—pancreatic cancer	0.00034	0.00117	CcSEcCtD
Sitagliptin—Somnolence—Fluorouracil—pancreatic cancer	0.00034	0.00117	CcSEcCtD
Sitagliptin—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000339	0.00116	CcSEcCtD
Sitagliptin—Face oedema—Doxorubicin—pancreatic cancer	0.000338	0.00116	CcSEcCtD
Sitagliptin—Malnutrition—Docetaxel—pancreatic cancer	0.000338	0.00116	CcSEcCtD
Sitagliptin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000338	0.00116	CcSEcCtD
Sitagliptin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000337	0.00116	CcSEcCtD
Sitagliptin—Nausea—Tamoxifen—pancreatic cancer	0.000336	0.00115	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000336	0.00115	CcSEcCtD
Sitagliptin—Fatigue—Gemcitabine—pancreatic cancer	0.000335	0.00115	CcSEcCtD
Sitagliptin—Constipation—Gemcitabine—pancreatic cancer	0.000333	0.00114	CcSEcCtD
Sitagliptin—Pain—Gemcitabine—pancreatic cancer	0.000333	0.00114	CcSEcCtD
Sitagliptin—Nausea—Erlotinib—pancreatic cancer	0.000333	0.00114	CcSEcCtD
Sitagliptin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000332	0.00114	CcSEcCtD
Sitagliptin—Diarrhoea—Sunitinib—pancreatic cancer	0.000332	0.00114	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00033	0.00113	CcSEcCtD
Sitagliptin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000329	0.00113	CcSEcCtD
Sitagliptin—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000328	0.00113	CcSEcCtD
Sitagliptin—Influenza—Epirubicin—pancreatic cancer	0.000327	0.00112	CcSEcCtD
Sitagliptin—Back pain—Docetaxel—pancreatic cancer	0.000327	0.00112	CcSEcCtD
Sitagliptin—Pain—Fluorouracil—pancreatic cancer	0.000327	0.00112	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000327	0.00112	CcSEcCtD
Sitagliptin—Muscle spasms—Docetaxel—pancreatic cancer	0.000325	0.00112	CcSEcCtD
Sitagliptin—Pancreatitis—Epirubicin—pancreatic cancer	0.000321	0.0011	CcSEcCtD
Sitagliptin—Dizziness—Sunitinib—pancreatic cancer	0.000321	0.0011	CcSEcCtD
Sitagliptin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000321	0.0011	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00032	0.0011	CcSEcCtD
Sitagliptin—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.00032	0.0011	CcSEcCtD
Sitagliptin—Breast disorder—Doxorubicin—pancreatic cancer	0.000317	0.00109	CcSEcCtD
Sitagliptin—Abdominal pain—Irinotecan—pancreatic cancer	0.000316	0.00108	CcSEcCtD
Sitagliptin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000315	0.00108	CcSEcCtD
Sitagliptin—Bronchitis—Epirubicin—pancreatic cancer	0.000315	0.00108	CcSEcCtD
Sitagliptin—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000313	0.00108	CcSEcCtD
Sitagliptin—Vomiting—Sunitinib—pancreatic cancer	0.000308	0.00106	CcSEcCtD
Sitagliptin—Rash—Sunitinib—pancreatic cancer	0.000306	0.00105	CcSEcCtD
Sitagliptin—Dermatitis—Sunitinib—pancreatic cancer	0.000305	0.00105	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000304	0.00104	CcSEcCtD
Sitagliptin—Urticaria—Fluorouracil—pancreatic cancer	0.000304	0.00104	CcSEcCtD
Sitagliptin—Headache—Sunitinib—pancreatic cancer	0.000304	0.00104	CcSEcCtD
Sitagliptin—Influenza—Doxorubicin—pancreatic cancer	0.000303	0.00104	CcSEcCtD
Sitagliptin—Weight increased—Epirubicin—pancreatic cancer	0.000298	0.00102	CcSEcCtD
Sitagliptin—DPP4—Peptide hormone metabolism—CTNNB1—pancreatic cancer	0.000298	0.0102	CbGpPWpGaD
Sitagliptin—Pancreatitis—Doxorubicin—pancreatic cancer	0.000297	0.00102	CcSEcCtD
Sitagliptin—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000295	0.00101	CcSEcCtD
Sitagliptin—Cough—Docetaxel—pancreatic cancer	0.000295	0.00101	CcSEcCtD
Sitagliptin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000294	0.00101	CcSEcCtD
Sitagliptin—Pneumonia—Epirubicin—pancreatic cancer	0.000294	0.00101	CcSEcCtD
Sitagliptin—Hypertension—Docetaxel—pancreatic cancer	0.000292	0.001	CcSEcCtD
Sitagliptin—Infestation—Epirubicin—pancreatic cancer	0.000292	0.001	CcSEcCtD
Sitagliptin—Infestation NOS—Epirubicin—pancreatic cancer	0.000292	0.001	CcSEcCtD
Sitagliptin—Bronchitis—Doxorubicin—pancreatic cancer	0.000291	0.001	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000289	0.000994	CcSEcCtD
Sitagliptin—Arthralgia—Docetaxel—pancreatic cancer	0.000288	0.000989	CcSEcCtD
Sitagliptin—Myalgia—Docetaxel—pancreatic cancer	0.000288	0.000989	CcSEcCtD
Sitagliptin—Nausea—Sunitinib—pancreatic cancer	0.000288	0.000988	CcSEcCtD
Sitagliptin—Renal failure—Epirubicin—pancreatic cancer	0.000287	0.000985	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	0.000287	0.00978	CbGpPWpGaD
Sitagliptin—Asthenia—Irinotecan—pancreatic cancer	0.000287	0.000984	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000286	0.000982	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000286	0.000982	CcSEcCtD
Sitagliptin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000284	0.000974	CcSEcCtD
Sitagliptin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000282	0.000967	CcSEcCtD
Sitagliptin—Dry mouth—Docetaxel—pancreatic cancer	0.000282	0.000967	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000282	0.000967	CcSEcCtD
Sitagliptin—Asthenia—Gemcitabine—pancreatic cancer	0.000279	0.000958	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000276	0.000948	CcSEcCtD
Sitagliptin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000276	0.000948	CcSEcCtD
Sitagliptin—Weight increased—Doxorubicin—pancreatic cancer	0.000276	0.000946	CcSEcCtD
Sitagliptin—Infection—Docetaxel—pancreatic cancer	0.000274	0.000941	CcSEcCtD
Sitagliptin—Sinusitis—Epirubicin—pancreatic cancer	0.000274	0.00094	CcSEcCtD
Sitagliptin—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000273	0.000938	CcSEcCtD
Sitagliptin—Diarrhoea—Irinotecan—pancreatic cancer	0.000273	0.000938	CcSEcCtD
Sitagliptin—Pneumonia—Doxorubicin—pancreatic cancer	0.000272	0.000933	CcSEcCtD
Sitagliptin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000271	0.000929	CcSEcCtD
Sitagliptin—Infestation NOS—Doxorubicin—pancreatic cancer	0.00027	0.000927	CcSEcCtD
Sitagliptin—Infestation—Doxorubicin—pancreatic cancer	0.00027	0.000927	CcSEcCtD
Sitagliptin—Skin disorder—Docetaxel—pancreatic cancer	0.000268	0.00092	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000268	0.000919	CcSEcCtD
Sitagliptin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000266	0.000914	CcSEcCtD
Sitagliptin—Renal failure—Doxorubicin—pancreatic cancer	0.000266	0.000912	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—PCSK1—pancreatic cancer	0.000266	0.00906	CbGpPWpGaD
Sitagliptin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000265	0.000909	CcSEcCtD
Sitagliptin—Dizziness—Irinotecan—pancreatic cancer	0.000264	0.000906	CcSEcCtD
Sitagliptin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000263	0.000901	CcSEcCtD
Sitagliptin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000262	0.000898	CcSEcCtD
Sitagliptin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000261	0.000895	CcSEcCtD
Sitagliptin—Pharyngitis—Epirubicin—pancreatic cancer	0.00026	0.000893	CcSEcCtD
Sitagliptin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000259	0.000888	CcSEcCtD
Sitagliptin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000258	0.000886	CcSEcCtD
Sitagliptin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000258	0.000884	CcSEcCtD
Sitagliptin—Urethral disorder—Epirubicin—pancreatic cancer	0.000257	0.000882	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000255	0.000877	CcSEcCtD
Sitagliptin—Vomiting—Irinotecan—pancreatic cancer	0.000254	0.000872	CcSEcCtD
Sitagliptin—Sinusitis—Doxorubicin—pancreatic cancer	0.000253	0.00087	CcSEcCtD
Sitagliptin—Dizziness—Fluorouracil—pancreatic cancer	0.000253	0.000868	CcSEcCtD
Sitagliptin—Rash—Irinotecan—pancreatic cancer	0.000252	0.000864	CcSEcCtD
Sitagliptin—Dermatitis—Irinotecan—pancreatic cancer	0.000252	0.000864	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000251	0.000863	CcSEcCtD
Sitagliptin—Headache—Irinotecan—pancreatic cancer	0.00025	0.000859	CcSEcCtD
Sitagliptin—Insomnia—Docetaxel—pancreatic cancer	0.00025	0.000857	CcSEcCtD
Sitagliptin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000248	0.000851	CcSEcCtD
Sitagliptin—Vomiting—Gemcitabine—pancreatic cancer	0.000247	0.000849	CcSEcCtD
Sitagliptin—Somnolence—Docetaxel—pancreatic cancer	0.000245	0.000842	CcSEcCtD
Sitagliptin—Rash—Gemcitabine—pancreatic cancer	0.000245	0.000842	CcSEcCtD
Sitagliptin—Dermatitis—Gemcitabine—pancreatic cancer	0.000245	0.000841	CcSEcCtD
Sitagliptin—Eye disorder—Epirubicin—pancreatic cancer	0.000245	0.000841	CcSEcCtD
Sitagliptin—Headache—Gemcitabine—pancreatic cancer	0.000244	0.000837	CcSEcCtD
Sitagliptin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000243	0.000835	CcSEcCtD
Sitagliptin—Vomiting—Fluorouracil—pancreatic cancer	0.000243	0.000835	CcSEcCtD
Sitagliptin—Dyspepsia—Docetaxel—pancreatic cancer	0.000243	0.000834	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.000243	0.00828	CbGpPWpGaD
Sitagliptin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000241	0.000828	CcSEcCtD
Sitagliptin—Rash—Fluorouracil—pancreatic cancer	0.000241	0.000828	CcSEcCtD
Sitagliptin—Dermatitis—Fluorouracil—pancreatic cancer	0.000241	0.000827	CcSEcCtD
Sitagliptin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000241	0.000826	CcSEcCtD
Sitagliptin—Decreased appetite—Docetaxel—pancreatic cancer	0.00024	0.000824	CcSEcCtD
Sitagliptin—Headache—Fluorouracil—pancreatic cancer	0.00024	0.000822	CcSEcCtD
Sitagliptin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000239	0.000822	CcSEcCtD
Sitagliptin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000239	0.00082	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000238	0.000818	CcSEcCtD
Sitagliptin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000238	0.000818	CcSEcCtD
Sitagliptin—Fatigue—Docetaxel—pancreatic cancer	0.000238	0.000817	CcSEcCtD
Sitagliptin—Angiopathy—Epirubicin—pancreatic cancer	0.000238	0.000816	CcSEcCtD
Sitagliptin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000238	0.000816	CcSEcCtD
Sitagliptin—Nausea—Irinotecan—pancreatic cancer	0.000237	0.000814	CcSEcCtD
Sitagliptin—Immune system disorder—Epirubicin—pancreatic cancer	0.000237	0.000813	CcSEcCtD
Sitagliptin—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000236	0.000811	CcSEcCtD
Sitagliptin—Constipation—Docetaxel—pancreatic cancer	0.000236	0.00081	CcSEcCtD
Sitagliptin—Pain—Docetaxel—pancreatic cancer	0.000236	0.00081	CcSEcCtD
Sitagliptin—Nausea—Gemcitabine—pancreatic cancer	0.000231	0.000793	CcSEcCtD
Sitagliptin—Mental disorder—Epirubicin—pancreatic cancer	0.00023	0.000788	CcSEcCtD
Sitagliptin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000229	0.000787	CcSEcCtD
Sitagliptin—Malnutrition—Epirubicin—pancreatic cancer	0.000228	0.000783	CcSEcCtD
Sitagliptin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000227	0.000781	CcSEcCtD
Sitagliptin—Nausea—Fluorouracil—pancreatic cancer	0.000227	0.00078	CcSEcCtD
Sitagliptin—Eye disorder—Doxorubicin—pancreatic cancer	0.000227	0.000778	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000226	0.000775	CcSEcCtD
Sitagliptin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000225	0.000773	CcSEcCtD
Sitagliptin—Flatulence—Epirubicin—pancreatic cancer	0.000225	0.000772	CcSEcCtD
Sitagliptin—Tension—Epirubicin—pancreatic cancer	0.000224	0.000769	CcSEcCtD
Sitagliptin—Nervousness—Epirubicin—pancreatic cancer	0.000222	0.000761	CcSEcCtD
Sitagliptin—Back pain—Epirubicin—pancreatic cancer	0.000221	0.000758	CcSEcCtD
Sitagliptin—Angiopathy—Doxorubicin—pancreatic cancer	0.00022	0.000755	CcSEcCtD
Sitagliptin—Muscle spasms—Epirubicin—pancreatic cancer	0.000219	0.000753	CcSEcCtD
Sitagliptin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000219	0.000752	CcSEcCtD
Sitagliptin—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000219	0.00075	CcSEcCtD
Sitagliptin—Abdominal pain—Docetaxel—pancreatic cancer	0.000218	0.000749	CcSEcCtD
Sitagliptin—Vision blurred—Epirubicin—pancreatic cancer	0.000215	0.000738	CcSEcCtD
Sitagliptin—Mental disorder—Doxorubicin—pancreatic cancer	0.000212	0.000729	CcSEcCtD
Sitagliptin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000212	0.000727	CcSEcCtD
Sitagliptin—Malnutrition—Doxorubicin—pancreatic cancer	0.000211	0.000725	CcSEcCtD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	0.00021	0.00716	CbGpPWpGaD
Sitagliptin—Flatulence—Doxorubicin—pancreatic cancer	0.000208	0.000714	CcSEcCtD
Sitagliptin—Tension—Doxorubicin—pancreatic cancer	0.000207	0.000711	CcSEcCtD
Sitagliptin—Malaise—Epirubicin—pancreatic cancer	0.000206	0.000706	CcSEcCtD
Sitagliptin—Nervousness—Doxorubicin—pancreatic cancer	0.000205	0.000704	CcSEcCtD
Sitagliptin—Vertigo—Epirubicin—pancreatic cancer	0.000205	0.000704	CcSEcCtD
Sitagliptin—Back pain—Doxorubicin—pancreatic cancer	0.000204	0.000701	CcSEcCtD
Sitagliptin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000203	0.000698	CcSEcCtD
Sitagliptin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000203	0.000697	CcSEcCtD
Sitagliptin—Cough—Epirubicin—pancreatic cancer	0.000199	0.000683	CcSEcCtD
Sitagliptin—Vision blurred—Doxorubicin—pancreatic cancer	0.000199	0.000683	CcSEcCtD
Sitagliptin—Asthenia—Docetaxel—pancreatic cancer	0.000198	0.00068	CcSEcCtD
Sitagliptin—Hypertension—Epirubicin—pancreatic cancer	0.000197	0.000676	CcSEcCtD
Sitagliptin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000196	0.000672	CcSEcCtD
Sitagliptin—Arthralgia—Epirubicin—pancreatic cancer	0.000194	0.000667	CcSEcCtD
Sitagliptin—Myalgia—Epirubicin—pancreatic cancer	0.000194	0.000667	CcSEcCtD
Sitagliptin—Anxiety—Epirubicin—pancreatic cancer	0.000194	0.000664	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000193	0.000662	CcSEcCtD
Sitagliptin—Discomfort—Epirubicin—pancreatic cancer	0.000192	0.000659	CcSEcCtD
Sitagliptin—Malaise—Doxorubicin—pancreatic cancer	0.00019	0.000653	CcSEcCtD
Sitagliptin—Dry mouth—Epirubicin—pancreatic cancer	0.00019	0.000652	CcSEcCtD
Sitagliptin—Vertigo—Doxorubicin—pancreatic cancer	0.00019	0.000651	CcSEcCtD
Sitagliptin—Diarrhoea—Docetaxel—pancreatic cancer	0.000189	0.000648	CcSEcCtD
Sitagliptin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000186	0.000639	CcSEcCtD
Sitagliptin—Infection—Epirubicin—pancreatic cancer	0.000185	0.000635	CcSEcCtD
Sitagliptin—Cough—Doxorubicin—pancreatic cancer	0.000184	0.000632	CcSEcCtD
Sitagliptin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000183	0.000627	CcSEcCtD
Sitagliptin—Dizziness—Docetaxel—pancreatic cancer	0.000183	0.000627	CcSEcCtD
Sitagliptin—Hypertension—Doxorubicin—pancreatic cancer	0.000182	0.000626	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000181	0.00619	CbGpPWpGaD
Sitagliptin—Skin disorder—Epirubicin—pancreatic cancer	0.000181	0.000621	CcSEcCtD
Sitagliptin—Myalgia—Doxorubicin—pancreatic cancer	0.00018	0.000617	CcSEcCtD
Sitagliptin—Arthralgia—Doxorubicin—pancreatic cancer	0.00018	0.000617	CcSEcCtD
Sitagliptin—Anxiety—Doxorubicin—pancreatic cancer	0.000179	0.000615	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000178	0.000613	CcSEcCtD
Sitagliptin—Discomfort—Doxorubicin—pancreatic cancer	0.000178	0.00061	CcSEcCtD
Sitagliptin—Dry mouth—Doxorubicin—pancreatic cancer	0.000176	0.000603	CcSEcCtD
Sitagliptin—Vomiting—Docetaxel—pancreatic cancer	0.000176	0.000603	CcSEcCtD
Sitagliptin—Rash—Docetaxel—pancreatic cancer	0.000174	0.000597	CcSEcCtD
Sitagliptin—Dermatitis—Docetaxel—pancreatic cancer	0.000174	0.000597	CcSEcCtD
Sitagliptin—Headache—Docetaxel—pancreatic cancer	0.000173	0.000594	CcSEcCtD
Sitagliptin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000172	0.000591	CcSEcCtD
Sitagliptin—Infection—Doxorubicin—pancreatic cancer	0.000171	0.000588	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00017	0.000582	CcSEcCtD
Sitagliptin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000169	0.00058	CcSEcCtD
Sitagliptin—Insomnia—Epirubicin—pancreatic cancer	0.000168	0.000578	CcSEcCtD
Sitagliptin—Skin disorder—Doxorubicin—pancreatic cancer	0.000167	0.000574	CcSEcCtD
Sitagliptin—Somnolence—Epirubicin—pancreatic cancer	0.000166	0.000568	CcSEcCtD
Sitagliptin—Nausea—Docetaxel—pancreatic cancer	0.000164	0.000563	CcSEcCtD
Sitagliptin—Dyspepsia—Epirubicin—pancreatic cancer	0.000164	0.000563	CcSEcCtD
Sitagliptin—Decreased appetite—Epirubicin—pancreatic cancer	0.000162	0.000556	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000161	0.000552	CcSEcCtD
Sitagliptin—Fatigue—Epirubicin—pancreatic cancer	0.000161	0.000551	CcSEcCtD
Sitagliptin—Pain—Epirubicin—pancreatic cancer	0.000159	0.000547	CcSEcCtD
Sitagliptin—Constipation—Epirubicin—pancreatic cancer	0.000159	0.000547	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000157	0.000539	CcSEcCtD
Sitagliptin—Insomnia—Doxorubicin—pancreatic cancer	0.000156	0.000535	CcSEcCtD
Sitagliptin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000153	0.000527	CcSEcCtD
Sitagliptin—Somnolence—Doxorubicin—pancreatic cancer	0.000153	0.000526	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000152	0.000523	CcSEcCtD
Sitagliptin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000152	0.000521	CcSEcCtD
Sitagliptin—Decreased appetite—Doxorubicin—pancreatic cancer	0.00015	0.000514	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000149	0.000511	CcSEcCtD
Sitagliptin—Fatigue—Doxorubicin—pancreatic cancer	0.000149	0.00051	CcSEcCtD
Sitagliptin—Urticaria—Epirubicin—pancreatic cancer	0.000148	0.000508	CcSEcCtD
Sitagliptin—Pain—Doxorubicin—pancreatic cancer	0.000147	0.000506	CcSEcCtD
Sitagliptin—Constipation—Doxorubicin—pancreatic cancer	0.000147	0.000506	CcSEcCtD
Sitagliptin—Abdominal pain—Epirubicin—pancreatic cancer	0.000147	0.000505	CcSEcCtD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000147	0.005	CbGpPWpGaD
Sitagliptin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000142	0.000487	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000141	0.000484	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—GCG—pancreatic cancer	0.000139	0.00476	CbGpPWpGaD
Sitagliptin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000137	0.000471	CcSEcCtD
Sitagliptin—Urticaria—Doxorubicin—pancreatic cancer	0.000137	0.00047	CcSEcCtD
Sitagliptin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000136	0.000468	CcSEcCtD
Sitagliptin—Asthenia—Epirubicin—pancreatic cancer	0.000134	0.000459	CcSEcCtD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000132	0.0045	CbGpPWpGaD
Sitagliptin—Diarrhoea—Epirubicin—pancreatic cancer	0.000127	0.000437	CcSEcCtD
Sitagliptin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000127	0.000436	CcSEcCtD
Sitagliptin—ABCB1—Allograft Rejection—AGTR1—pancreatic cancer	0.000124	0.00424	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	0.000124	0.00423	CbGpPWpGaD
Sitagliptin—Asthenia—Doxorubicin—pancreatic cancer	0.000124	0.000424	CcSEcCtD
Sitagliptin—Dizziness—Epirubicin—pancreatic cancer	0.000123	0.000423	CcSEcCtD
Sitagliptin—Vomiting—Epirubicin—pancreatic cancer	0.000118	0.000406	CcSEcCtD
Sitagliptin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000118	0.000405	CcSEcCtD
Sitagliptin—Rash—Epirubicin—pancreatic cancer	0.000117	0.000403	CcSEcCtD
Sitagliptin—Dermatitis—Epirubicin—pancreatic cancer	0.000117	0.000403	CcSEcCtD
Sitagliptin—Headache—Epirubicin—pancreatic cancer	0.000117	0.0004	CcSEcCtD
Sitagliptin—Dizziness—Doxorubicin—pancreatic cancer	0.000114	0.000391	CcSEcCtD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000112	0.00381	CbGpPWpGaD
Sitagliptin—Nausea—Epirubicin—pancreatic cancer	0.000111	0.00038	CcSEcCtD
Sitagliptin—Vomiting—Doxorubicin—pancreatic cancer	0.00011	0.000376	CcSEcCtD
Sitagliptin—Rash—Doxorubicin—pancreatic cancer	0.000109	0.000373	CcSEcCtD
Sitagliptin—Dermatitis—Doxorubicin—pancreatic cancer	0.000109	0.000373	CcSEcCtD
Sitagliptin—Headache—Doxorubicin—pancreatic cancer	0.000108	0.00037	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	0.000106	0.00362	CbGpPWpGaD
Sitagliptin—Nausea—Doxorubicin—pancreatic cancer	0.000102	0.000351	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	0.000101	0.00346	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—PTGS2—pancreatic cancer	9.73e-05	0.00332	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	9.29e-05	0.00317	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	9.11e-05	0.00311	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	9.04e-05	0.00308	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	8.33e-05	0.00284	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	8.22e-05	0.00281	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—MMP2—pancreatic cancer	7.34e-05	0.0025	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	7.19e-05	0.00245	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	7.07e-05	0.00241	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	6.24e-05	0.00213	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CXCL8—pancreatic cancer	6.1e-05	0.00208	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	6.05e-05	0.00206	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	5.7e-05	0.00194	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CTNNB1—pancreatic cancer	5.62e-05	0.00192	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	5.47e-05	0.00187	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	5.46e-05	0.00186	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	5.35e-05	0.00182	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	5.3e-05	0.00181	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	5.21e-05	0.00178	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	4.63e-05	0.00158	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	4.25e-05	0.00145	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TNF—pancreatic cancer	3.97e-05	0.00135	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	3.94e-05	0.00135	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.78e-05	0.00129	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.44e-05	0.00117	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	3.41e-05	0.00116	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PRSS1—pancreatic cancer	3.24e-05	0.00111	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.9e-05	0.000989	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.83e-05	0.000964	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ARG2—pancreatic cancer	2.81e-05	0.00096	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.69e-05	0.000918	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.62e-05	0.000894	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.6e-05	0.000885	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.53e-05	0.000863	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TYMP—pancreatic cancer	2.46e-05	0.000839	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ARG2—pancreatic cancer	2.45e-05	0.000836	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.35e-05	0.0008	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.28e-05	0.000779	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TYMP—pancreatic cancer	2.14e-05	0.000731	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.1e-05	0.000717	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.1e-05	0.000715	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.06e-05	0.000701	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.03e-05	0.000692	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.98e-05	0.000676	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.96e-05	0.000668	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.95e-05	0.000665	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.94e-05	0.000663	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.85e-05	0.000631	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.83e-05	0.000625	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.78e-05	0.000609	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.77e-05	0.000603	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.74e-05	0.000594	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.73e-05	0.000589	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.73e-05	0.000589	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—DPYD—pancreatic cancer	1.7e-05	0.000579	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.61e-05	0.00055	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.61e-05	0.000549	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.51e-05	0.000515	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.46e-05	0.000497	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CD44—pancreatic cancer	1.43e-05	0.000489	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.4e-05	0.000479	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.39e-05	0.000474	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GCG—pancreatic cancer	1.37e-05	0.000469	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.32e-05	0.00045	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—STK11—pancreatic cancer	1.29e-05	0.000441	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CD44—pancreatic cancer	1.25e-05	0.000426	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.21e-05	0.000414	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GCG—pancreatic cancer	1.2e-05	0.000408	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—STK11—pancreatic cancer	1.13e-05	0.000384	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.11e-05	0.000379	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.06e-05	0.000363	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.05e-05	0.000357	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	9.93e-06	0.000339	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TYMS—pancreatic cancer	9.68e-06	0.00033	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—APOE—pancreatic cancer	9.04e-06	0.000308	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.55e-06	0.000292	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	8.16e-06	0.000278	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—APOE—pancreatic cancer	7.87e-06	0.000269	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PPARG—pancreatic cancer	7.87e-06	0.000268	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CD44—pancreatic cancer	7.69e-06	0.000262	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GCG—pancreatic cancer	7.37e-06	0.000252	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	7.17e-06	0.000245	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CG—pancreatic cancer	7.1e-06	0.000242	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—STK11—pancreatic cancer	6.93e-06	0.000236	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PPARG—pancreatic cancer	6.86e-06	0.000234	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	6.25e-06	0.000213	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CD—pancreatic cancer	6.25e-06	0.000213	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS2—pancreatic cancer	6.19e-06	0.000211	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.96e-06	0.000203	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CB—pancreatic cancer	5.44e-06	0.000186	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTEN—pancreatic cancer	5.4e-06	0.000184	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS2—pancreatic cancer	5.39e-06	0.000184	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—APOE—pancreatic cancer	4.85e-06	0.000165	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTEN—pancreatic cancer	4.7e-06	0.00016	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.38e-06	0.000149	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.22e-06	0.000144	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.85e-06	0.000131	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	3.81e-06	0.00013	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.35e-06	0.000114	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.32e-06	0.000113	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.32e-06	0.000113	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AKT1—pancreatic cancer	3.11e-06	0.000106	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.9e-06	9.89e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AKT1—pancreatic cancer	2.71e-06	9.25e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.04e-06	6.97e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.67e-06	5.7e-05	CbGpPWpGaD
